Rarer ones include gallbladder problems, pancreatitis, and gastroparesis, a chronic stomach condition that can cause serious pain, vomiting, and malnutrition
For this population, recommendations should emphasize shifting dietary fat intake and adjusting macronutrient distribution, specifically, reallocating calories to fiber-rich carbohydrates and protein
Compared to newer GLP-1s, Victoza leads to modest A1C lowering and weight loss
The theoretical rationale involves BPC-157 protective effects on gastric mucosa, which could offset the GI disturbance that tirzepatide produces
24.2% weight loss at 48 weeks (Phase 2)
We are known to be an overfed but malnourished population